Clinical trial
Methylphenidate for Depressed Cancer Patients Receiving Palliative Care
NCT00129467 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00129467 |
|---|---|
| Title | Methylphenidate for Depressed Cancer Patients Receiving Palliative Care |
| Official title | Methylphenidate for Depressed Cancer Patients in Hospice |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Oregon Health and Science University |
| Status | Completed |
| Study type | Interventional |
| Conditions | Depression, Palliative Care, Cancer, Mental Disorder |
| Intervention type | Drug |
| Interventions | Methylphenidate, Placebo, Selective Serotonin Uptake Inhibitor (SSRI) |
| Enrollment | 47 |
| Start date | Feb 1, 2005 |
| Primary completion | Sep 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Aug 11, 2005 |
| Last update posted | Apr 24, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: